How many drugs treat Ovale malaria?

Drug Landscape tracks 4 marketed treatments for Ovale malaria (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/ovale-malaria.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Ovale malaria — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ovale malaria (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Ovale malaria, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Hydroxychloroquine Sulfate	HYDROXYCHLOROQUINE	Advanz	Antimalarial	Toll-like receptor 9	1955-01-01
Aralen	CHLOROQUINE	Sanofi	Antimalarial	Sigma non-opioid intracellular receptor 1	1949-01-01
Hydroxychloroquin	Hydroxychloroquin	Children's Hospital of Fudan University		Transmembrane protein 97, Alpha-1D adrenergic receptor, Alpha-2A adrenergic receptor
Hydroxychloroquine Sulfate	hydroxychloroquine-pill	Sanofi	Antimalarial	Toll-like receptor 9	1955-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Sanofi · 2 drugs in Ovale malaria
Advanz · 1 drug in Ovale malaria
Children's Hospital of Fudan University · 1 drug in Ovale malaria

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Ovale malaria:

Cite this brief

Drug Landscape (2026). Ovale malaria — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/ovale-malaria. Accessed 2026-06-10.

Ovale malaria full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing